Addus HomeCare (ADUS) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

Addus HomeCare

NasdaqGS•Healthcare•Medical Care Facilities

$117.92-0.59(<0.01%)Market open

Market Cap

$2.17B

P/E

20.6x

P/S

1.5x

P/B

1.9x

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. Its Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. Its Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.

How this company scores

ExcellentMetricSide Score: 91/100

Strongest: Balance Sheet & Red Flags (25/25); weakest: Profitability (18/25).

Profitability18/25

Growth23/25

Balance Sheet & Red Flags25/25

Cash & Earnings Quality25/25

Strengths

Growing revenueRising free cash flowRising earningsLow leverage

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 20.6x5y range 17.2x – 34.4x

Currently below its 20-quarter median.

P/S · 1.5x5y range 1.2x – 2.1x

Currently near its 20-quarter median.

P/B · 1.9x5y range 1.5x – 2.6x

Watch items

Data-driven signals worth keeping an eye on across the last 8 quarters

Some Concerns

Share Dilution

Watch

Shares outstanding rose 2.4% — mild dilution. Compare to earnings growth to assess the net per-share impact.

Price & Volume

Market Cap $2.17B

Metrics at a Glance

as of June 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $1.48B
Q. Revenue: $377.42M
TTM EBITDA: $164.94M
TTM Op. Income: $148.23M
Q. Op. Income: $38.94M
TTM Net Income: $105.31M
Q. Net Income: $27.61M
EPS: $1.51
Shares Out.: $18.29M

$1.48B in TTM revenue grew 15.9% YoY, reaching $377.42M last quarter. TTM EBITDA of $164.94M and TTM operating income of $148.23M show growth is flowing through to the bottom line. TTM net income of $105.31M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 32.2%
EBITDA Margin: 11.4%
Op. Margin: 10.3%
Net Margin: 7.3%

Op. margin of 10.3% is up 0.9% YoY — cost efficiency is improving. Net margin at 7.3% and gross margin of 32.2% show how much of each revenue dollar survives to profit. Over the past year, operating margin is up 10% — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 20.6x
P/S Ratio: 1.5x
P/B Ratio: 1.9x

At 20.6x P/E, the stock trades within typical market levels. P/S of 1.5x and P/B of 1.9x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Over the past year, P/E is down 18% — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $1.46B
Cash: $99.57M
Long-Term Debt: $61.60M
Book Value: $1.15B
D/E Ratio: 0.1
Debt/EBITDA: 1.4

With $1.46B in assets and $61.60M in long-term debt, D/E is 0.1and book value is $1.15B — a conservative capital structure with a cushion to weather downturns. Across the last 7 quarters, debt/equity has fallen for 6 consecutive quarters — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $40.01M
TTM Free Cash Flow: $154.77M
FCF Margin: 10.5%
FCF / Net Income: 1.5

TTM FCF of $154.77M on $40.01M in operating cash flow. The FCF / Net Income ratio of 1.5x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 5 consecutive quarters — an improving trend.